Stock analysis is used by traders to make buy and sell call. It’s an approach to make informed decisions while investing in stocks. Stock analysis can be categorised into – fundamental analysis and technical analysis. Fundamental analysis is evaluation of data from sources, including financial records, economic reports, company assets, and market share. Analysts typically study the company’s financial statements – balance sheet, income statement, cash flow statement, and footnotes. These statements are made available to the investors in the form of quarterly earnings, disclosures to stock exchanges in compliance with the Securities and Exchange Board of India (Sebi) norms. In fundamental analysis, the analysts particularly check for a company's core income, income from other sources, profitability, guidance, assets and liabilities and debt ratio among other parameters. The other method, i.e. the technical analysis focuses purely on statistical data. It works on two assumptions; one, the stock price reflects the fundamentals. Second, the study of past and present movement in prices can help determine the future price trends. Technical analysis primarily deals with price, volume, demand and supply factors. This method is effective only when supply and demand forces influence the market. However, when outside factors are involved in a price movement, technical analysis may not be successful. More
Ashwani Gujral of ashwanigujral.com recommends buying VIP Industries and Divis Laboratories and feels that L&T is likely to test Rs 1400 in six months while he advises selling Arvind.
Ashwani Gujral of ashwanigujral.com suggests buying Motherson Sumi Systems, HPCL and Divis Laboratories.
According to Ashwani Gujral of ashwanigujral.com, one can buy Bajaj Auto, Sun TV, Mahindra Lifespace, Jai Corp, Balkrishna Industries, Indiabulls Real Estate and Divis Laboratories.
The ongoing re-inspection at Unit 2 of Divi's Laboratories remains in focus. In an interview to CNBC-TV18, Amey Chalke of HDFC Securities shared his expectations.
Sudarshan Sukhani of s2analytics.com is of the view that one can buy Bata India, Indraprastha Gas and M&M Financial Services and advises holding Jain Irrigation Systems while he suggests selling Rico Auto.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy IIFL Holdings, Yes Bank, IGL and Bajaj Finance and feels that Divis Lab is likely to hit Rs 1000.
Ashwani Gujral of ashwanigujral.com recommends buying Divis Laboratories, Reliance Industries and HDFC Bank.
Ashwani Gujral of ashwanigujral.com recommends buying Berger Paints, REC and Wockhardt.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
Prakash Gaba of prakashgaba.com is of the view that Bharat Financial Inclusion can head towards Rs 1000.
Kotak Mahindra Bank, Sun Pharmaceuticals, and United Breweries, among others are on the radar of investors on Wednesday.
Aditya Birla Money feels the Nifty trading range for first few days of September series would be 9,650-10,050.
Mitessh Thakkar of mitesshthakkar.com is of the view that one can buy Aurobindo Pharma, Bajaj Finserv and Bharat Electronics and sell Motherson Sumi Systems.
According to Technical Analyst Prakash Gaba of prakashgaba.com, crucial support for the Nifty is at 9785 and the resistance is at 9911. Bank Nifty on the other hand has support at 24074 and resistance at 24511.
Moneycontrol analysed pharma stocks with a market cap of over Rs 1,000 crore. In order to find out if there are any scrips available at a reasonable valuation, we used five-year average price-to-earnings as a filter
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
Ashwani Gujral of ashwanigujral.com is of the view that one can buy Edelweiss Financial Services and Titan Company and can sell Sun Pharmaceutical Industries, Granules India and Divis Laboratories.
Sumeet Jain of Destimoney Securities is of the view that one may sell Divis Lab Future with a target of Rs 594.
Expectation of some bit of consolidation cannot be ruled out in the coming week and investors will be better off taking bets on individual stocks.
In an interview to CNBC-TV18's Surabhi Upadhyay and Prashant Nair, SP Tulsian of sptulsian shared his views and outlook on the fundamentals of the market and specific stocks.
Prakash Gaba of prakashgaba.com is of the view that some sideways action is not ruled out. The crucial support for the Nifty is at 9920 and the resistance is at 10036-10069. On the other hand, Bank Nifty has support at 24775 and resistance at 25550.
Ashwani Gujral of ashwanigujral.com recommends buying HPCL, Divis Laboratories, SPARC, Capital First, Idea Cellular and Welspun Corp.
Ashwani Gujral of ashwanigujral.com recommends buying Dewan Housing Finance, HDFC Bank and Bajaj Finserv.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.
In an interview to CNBC-TV18's Anuj Singhal and Surabhi Upadhyay, SP Tulsian of sptulsian.com shared his views and outlook on the fundamentals of the market and specific stocks.